# A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers

> **NCT07029932** · PHASE1 · RECRUITING · sponsor: **Bugworks Research Inc.** · enrollment: 48 (estimated)

## Conditions studied

- Infectious Diseases
- Antimicrobial Drug Resistance

## Interventions

- **DRUG:** BWC0977
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07029932
- **Lead sponsor:** Bugworks Research Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-10
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 48 (ESTIMATED)
- **Last updated:** 2025-11-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07029932

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07029932, "A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT07029932. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*